H

HERRICK A

Last name: HERRICK A

2018 (v1)

Publication

Metadata-only

There is a need for new systemic sclerosis subset criteria. A content analytic approach

Johnson SR Soowamber ML Fransen J

Objectives. Systemic sclerosis (SSc) is heterogenous. The objectives of this study were to evaluate the purpose, strengths and limitations of existing SSc subset criteria, and identify ideas among experts about subsets. Methods. We conducted semi-structured interviews with randomly sampled international SSc experts. The interview transcripts...

Uploaded on: April 14, 2023
2010 (v1)

Publication

Metadata-only

Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database.

Avouac J Walker U Tyndall A

No description

Uploaded on: March 31, 2023
2019 (v1)

Publication

Metadata-only

Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease

Distler O Highland KB Gahlemann M

BACKGROUND: Interstitial lung disease (ILD) is a common manifestation of systemic sclerosis and a leading cause of systemic sclerosis-related death. Nintedanib, a tyrosine kinase inhibitor, has been shown to have antifibrotic and antiinflammatory effects in preclinical models of systemic sclerosis and ILD. METHODS: We conducted a randomized,...

Uploaded on: April 14, 2023